ALLR Allarity Therapeutics, Inc.
Healthcare$1.69-4.80%ClosedMarket Cap: $26.8M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
4.08
P/S
81.63
EV/EBITDA
-2.69
DCF Value
$1.33
FCF Yield
-59.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
107.5%
Operating Margin
-3552.8%
Net Margin
-3260.6%
ROE
-109.9%
ROA
-32.2%
ROIC
-43.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $25.0K | 204.0% | $-2.7M | $-2.8M | $— | — |
| Q4 null | $320.0K | 100.0% | $-2.9M | $-3.4M | $— | — |
| FY null | $320.0K | 100.0% | $-12.6M | $-11.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-2.5M | $-2.8M | $— | — |
| Q2 null | $0.00 | NaN% | $-4.1M | $-2.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-3.0M | $-2.7M | $— | — |
| Q4 null | $0.00 | NaN% | $-7.3M | $-7.5M | $— | — |
| FY null | $0.00 | NaN% | $-27.2M | $-24.5M | $— | — |
| Q3 null | $0.00 | NaN% | $-12.3M | $-11.6M | $— | — |
| Q2 null | $0.00 | NaN% | $-3.4M | $-1.6M | $— | — |
| Q1 null | $0.00 | NaN% | $-4.2M | $-3.8M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-4.9M | $-1.7M | $-175.51 | — |